FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/08/2026
Voltar para busca
Dado oficial do USPTO
S SEAMLESS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
40
Atualização mais recente
05/08/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 42
Data de depósito
14/12/2023
Data de registro
05/05/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/05/2026
Última transação
05/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
27
Localização do titular
DE
Examinador
MESSICK, TABITHA LEE
Unidade examinadora
L40
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the wording "SEAMLESS" in stylized font in gradient from blue to green next to the letter "S" comprised of curved bands in green and blue.
Titulares e representantes
Titulares
Seamless Therapeutics GmbH
Representantes
Brian J. Focarino COOLEY LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in industry and science; biological preparations for use in industry and sciencebiological reagentsfor use in industry and sciencenot for medical purposes
Classe 5
Pharmaceutical and biological preparations for gene therapies and gene-editing therapiesall for the treatment of genetic and viral diseases; medicalpharmaceutical and biopharmaceutical preparations and substances containing programmable recombinases for the treatment of genetic and viral diseases; pharmaceutical goods and preparationsgene transferregulationmodulation and delivery medications for the treatment of genetic and viral diseases and disorders; productsagentsfor medical purposesfor veterinary purposes in the nature of pharmaceutical preparations for cellulargenome and gene editing therapies to treat geneticoncologicalimmune system-relatedinflammatory disorders and diseases; genome editable enzymes being enzymes for medical purposes; DNA recombinant enzymes being enzymes for medical purposes; DNA editable enzymesespeciallyrecombinases and integrases being enzymes for medical purposes; genome editable enzymes for the treatment of diseases being enzymes for medical purposes; DNA recombinant enzymes for the treatment of diseases being enzymes for medical purposes; DNA editable enzymesin particular recombinases and integrasesfor the treatment of diseases being enzymes for medical purposes
Classe 42
Scientific and technological servicesproduct research and testing of pharmaceuticals for cell and gene therapies in the field of pharmaceutical product development for the creation of bioinformatic algorithms and models; development of pharmaceutical preparations and medicinesnone of the foregoing for diagnostics; pharmaceutical product developmentnone of the foregoing for diagnostics; pharmaceutical products development of genome editable enzymes for treatment and not diagnostic purposes; pharmaceutical products development of DNA editable enzymesin particular recombinases and integrasesfor treatment and not diagnostic purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
40 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
25/06/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/05/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
05/05/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
16/04/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
30/03/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
29/03/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
19/03/2026
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
19/03/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
19/03/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
19/03/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/03/2026
PUBO
PUBLISHED FOR OPPOSITION
17/03/2026
GPNX
NOTIFICATION PROCESSED BY IB
12/03/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/03/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
25/02/2026
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
24/02/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/02/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
18/02/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
18/02/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
18/02/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
18/02/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/01/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/01/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/01/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
15/07/2025
GNRT
NON-FINAL ACTION E-MAILED
15/07/2025
CNRT
NON-FINAL ACTION WRITTEN
15/07/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/05/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/05/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/05/2025
RFNT
REFUSAL PROCESSED BY IB
14/12/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
22/11/2024
RFRR
REFUSAL PROCESSED BY MPU
22/11/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
15/11/2024
CNRT
NON-FINAL ACTION WRITTEN
14/11/2024
DOCK
ASSIGNED TO EXAMINER
05/11/2024
MAFR
APPLICATION FILING RECEIPT MAILED
04/11/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/11/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
31/10/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace S SEAMLESS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.